Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Second-line Melanoma”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Testing effectiveness (Phase 2)WithdrawnNCT05338580
What this trial is testing

Clinical Trial of TJ271 Injection Combined With Pembrolizumab in the Treatment of Advanced Solid Tumors

Who this might be right for
First-line Non-small-cell Lung CancerFirst-line Urothelial CarcinomaSecond-line Urothelial Carcinoma+1 more
TJ Biopharma Co., Ltd.
Not applicableNot Yet RecruitingNCT06553781
What this trial is testing

A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Cadonilimab Injection and Temozolomide in Second-line and Subsequent Treatment of Advanced Melanoma

Who this might be right for
Malignant Melanoma
Fudan University 28
Not applicableUnknownNCT02581228
What this trial is testing

Multi-Centre, Retrospective, Open Label Study, to Validate ML-PrediCare by Patients With Melanoma Under 1st and 2nd Lines of Immunotherapy

Who this might be right for
Melanoma
Optimata Ltd. 500
Testing effectiveness (Phase 2)Study completedNCT00612664
What this trial is testing

Phase II, 2nd Line Melanoma - RAND Monotherapy

Who this might be right for
Melanoma
Bristol-Myers Squibb 158
Not applicableWithdrawnNCT03161613
What this trial is testing

Study to Assess the Safety of Nivolumab in the Treatment of Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Chronic Hodgkin Lymphoma in Adults in Mexico

Who this might be right for
Multiple Indications Cancer
Bristol-Myers Squibb
Testing effectiveness (Phase 2)UnknownNCT01168050
What this trial is testing

Efficacy of Nilotinib in First or Second Line Treatment of Primary Melanomas Stage III Unresectable Melanomas.

Who this might be right for
Malignant Skin Melanoma T0Stage III MelanomaStage IV Melanoma+1 more
Assistance Publique - Hôpitaux de Paris 25
Testing effectiveness (Phase 2)Study completedNCT00383292
What this trial is testing

Tasisulam in Treating Participants With Malignant Melanoma

Who this might be right for
Metastatic Melanoma
Eli Lilly and Company 130
Testing effectiveness (Phase 2)Study completedNCT02223884
What this trial is testing

Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Failed First-Line Dacabazine or Temozolomide Contained Therapy

Who this might be right for
Malignant Melanoma
Yonsei University 30
Testing effectiveness (Phase 2)UnknownNCT03383237
What this trial is testing

Clinical Study of Apatinib as the Second-line Therapy in Malignant Melanoma

Who this might be right for
Malignant Melanoma
Henan Cancer Hospital 20
Post-approval studies (Phase 4)UnknownNCT00226473
What this trial is testing

Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma

Who this might be right for
Metastatic Melanoma
Dermatologic Cooperative Oncology Group 200
Testing effectiveness (Phase 2)Looking for participantsNCT05361174
What this trial is testing

Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Who this might be right for
Unresectable MelanomaMetastatic MelanomaStage III Non-small Cell Lung Cancer+1 more
Iovance Biotherapeutics, Inc. 53
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06670300
What this trial is testing

Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer

Who this might be right for
Participants Who Had Received Second-line or Higher Advanced Melanoma and Advanced Renal Cancer
YongZhang 20
Large-scale testing (Phase 3)Ended earlyNCT01006252
What this trial is testing

Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma

Who this might be right for
Melanoma
Eli Lilly and Company 336
Testing effectiveness (Phase 2)UnknownNCT02501551
What this trial is testing

Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy

Who this might be right for
Melanoma
Yonsei University 36
Testing effectiveness (Phase 2)UnknownNCT01092585
What this trial is testing

Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH

Who this might be right for
Melanoma
Genta Incorporated 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07347444
What this trial is testing

Iparomlimab and Tuvoraleimab Injection in Combination With Bevacizumab, Albumin-bound Paclitaxel, and Carboplatin as First- or Second-line Treatment for Patients With Advanced Acral and Mucosal Melanoma

Who this might be right for
Acral MelanomaMucosal Melanoma
Fudan University 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT05081609
What this trial is testing

Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
Advanced Solid TumorLocally Advanced Solid TumorMetastatic Solid Tumor+10 more
Ascendis Pharma Oncology Division A/S 320
Testing effectiveness (Phase 2)UnknownNCT03514901
What this trial is testing

To Evaluate the Efficacy Beyond Progression of Vemurafenib+Cobimetinib Associated With Local Treatment Compared to Second-line Treatment in Patients With BRAFV600+ Metastatic Melanoma in Focal Progression With First-line+Vemurafenib+Cobimetinib.

Who this might be right for
Melanoma MetastaticBRAF V600 Mutation
Intergruppo Melanoma Italiano 120
Testing effectiveness (Phase 2)Ended earlyNCT00735332
What this trial is testing

Efficacy Study of TLN-232 in Patients With Recurring Metastatic Melanoma

Who this might be right for
Melanoma
Thallion Pharmaceuticals 49
Testing effectiveness (Phase 2)Study completedNCT01064713
What this trial is testing

Phase II Study of Tesetaxel in Metastatic Melanoma

Who this might be right for
Advanced MelanomaCancer
M.D. Anderson Cancer Center 17
Next Page